Megasarfoser 300 mg Modified Release (Sarpogrelate Hydrochloride)

Adult dose

Sarpogrelate Hydrochloride modified release 300 mg is administered orally once a day after meals. This medication should be taken whole and not chewed or crushed.

This medication should not be administered to patients with bleeding. This is because bleeding may worsen in conditions such as hemophilia or gastrointestinal ulcers where there is a risk of bleeding. It is advisable for pregnant women or women of childbearing age to avoid taking this drug, as negative effects on the fetus have been reported in animal experiments. Women who are menstruating, patients with a tendency to bleed, and those taking anticoagulants or platelet aggregation inhibitors should use this drug with caution. There may be an increased risk of bleeding. Patients with severe kidney dysfunction or the elderly also need to be cautious when using this drug. Physical conditions can affect the excretion or action of the medication. During the use of this medication, various side effects such as urticaria, dyspepsia, diarrhea, headaches, blood pressure changes may occur, so the patient’s condition should be closely monitored. Particularly, if symptoms of bleeding, severe allergic reactions, or liver function abnormalities occur, consult a doctor immediately. For those taking this medication for a long time, regular blood tests are recommended to detect bleeding risks or blood abnormalities early. Caution is needed when taking this medication alongside anticoagulants or platelet aggregation inhibitors, as it may increase bleeding risks; inform your healthcare provider if you are taking such medications. Pregnant or breastfeeding women are advised to avoid this drug, and if unavoidable, it is safer to stop breastfeeding. Safety for children has not been established, so it is recommended not to use it in children. Lastly, this medication should be stored out of the reach of children, and transferring it to another container may affect its quality, so caution is advised.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Rhinitis
• conjunctivitis
• upper respiratory tract infections
• dyspepsia
• constipation
• diarrhea
• gastritis
• gastrointestinal dysfunction
• hypoglycemia
• decreased appetite

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. Also, it is essential to keep the medication at room temperature, specifically between 1°C and 30°C, without being too hot or too cold.

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle